Tatsuki Mochizuki
Chugai Pharma (United States)(US)Toa Pharmaceutical (Japan)(JP)
Publications by Year
Research Areas
Drug Transport and Resistance Mechanisms, Pharmacogenetics and Drug Metabolism, Pharmacological Effects and Toxicity Studies, Drug Solubulity and Delivery Systems, Nanoparticle-Based Drug Delivery
Most-Cited Works
- → Expression and Functional Characterization of Drug Transporters in Brain Microvascular Endothelial Cells Derived from Human Induced Pluripotent Stem Cells(2018)78 cited
- → Omega-3 fatty acid epoxides are autocrine mediators that control the magnitude of IgE-mediated mast cell activation(2017)54 cited
- → Elucidation of N1-methyladenosine as a Potential Surrogate Biomarker for Drug Interaction Studies Involving Renal Organic Cation Transporters(2019)40 cited
- → Involvement of Organic Cation Transporters in the Kinetics of Trimethylamine N-oxide(2017)39 cited
- → Effect of Cyclosporin A and Impact of Dose Staggering on OATP1B1/1B3 Endogenous Substrates and Drug Probes for Assessing Clinical Drug Interactions(2022)35 cited
- → Physiologically‐based pharmacokinetic model‐based translation of OATP1B‐mediated drug–drug interactions from coproporphyrin I to probe drugs(2022)30 cited
- → Modulation of blood-brain barrier function by a heteroduplex oligonucleotide in vivo(2018)28 cited
- → Current progress in identifying endogenous biomarker candidates for drug transporter phenotyping and their potential application to drug development(2020)28 cited
- → Functional Investigation of Solute Carrier Family 35, Member F2, in Three Cellular Models of the Primate Blood-Brain Barrier(2020)23 cited
- → Cluster Gauss‐Newton method analyses of PBPK model parameter combinations of coproporphyrin‐I based on OATP1B‐mediated rifampicin interaction studies(2022)19 cited